Healthcare & Pharmaceuticals
Nanoparticle-based Influenza Vaccine
A recombinant protein-based intranasal influenza vaccine using graphene oxide nanoparticles that imparts both systematic and mucosal immunity to confer broad cross-protection against heterologous and heterosubtypic strains (GSU 2021-006)